4/A
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-009724
Director bought 194,445 shares at $18.00 ($3,500,010)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Belldegrun Arie Director | 2018-10-15 | Purchase | +194,445 | $18.00 | $3,500,010 | 1,691,781 | I: show line 1 in the form |
| Open-market purchases · 194,445 sh · avg $18.00 · $3,500,010 | |||||||
Loading xslF345X03/doc4a.xml…